Blood cancer: AOP Health announces new findings in patients with polycythemia vera published in medical journal Leukemia
Vienna, Vienna, September 18th, 2023.
AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with polycythemia vera (PV) in the...
Zur Pressemeldung auf www.aop-health.com